Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for YCBD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 11.12M
March 31, 2026 10.50M
December 31, 2025 10.07M
September 30, 2025 8.917M
June 30, 2025 8.908M
March 31, 2025 0.7834M
December 31, 2024 5.543M
September 30, 2024 3.939M
June 30, 2024 3.759M
March 31, 2024 3.045M
December 31, 2023 2.961M
September 30, 2023 2.961M
June 30, 2023 2.855M
March 31, 2023 1.457M
December 31, 2022 1.349M
September 30, 2022 1.348M
June 30, 2022 1.332M
March 31, 2022 1.318M
Date Value
December 31, 2021 1.295M
September 30, 2021 1.284M
June 30, 2021 1.266M
March 31, 2021 1.252M
December 31, 2020 1.158M
September 30, 2020 1.158M
June 30, 2020 1.141M
March 31, 2020 1.141M
December 31, 2019 0.616M
September 30, 2019 0.616M
June 30, 2019 0.077M
March 31, 2019 0.0283M
December 31, 2018 0.028M
September 30, 2018 0.1805M
June 30, 2018 0.1804M
March 31, 2018 0.1785M
December 31, 2017 0.1733M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Tilray Brands, Inc. 131.09M
Organogenesis Holdings, Inc. 128.67M
Guardian Pharmacy Services, Inc. 63.33M
Nektar Therapeutics 34.13M
Elite Pharmaceuticals, Inc. 1.077B